About Abselion
Amperia by Abselion enables simple, reliable biomolecule quantification across biologics workflows. Quantify antibodies, AAV capsids and His-tagged proteins.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Cambridge, United Kingdom
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
abselion.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
@AbselionX
(8 followers)
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $8,860,000 · Series-A
Backed by M Ventures
Investors & Backers
M Ventures
Lead
BioProcess360 Partners
Business Growth Fund
New Ground Ventures
Parkwalk Advisors
R42 Group
Swiss Health Angels
University of Cambridge Enterprise
UNTITLED
Funding History
Series-A equity
· Dec 4, 2024
Round backers: M Ventures
$8,860,000 startupintros.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026